Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics

Introduction Osteosarcoma (OS) is a highly aggressive primary bone malignancy with poor prognosis. Histone modifications play crucial roles in tumor progression, but their systematic investigation in OS remains unexplored. Methods This study integrated single-cell RNA sequencing data and large-scale...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Yang MD, Xinqiao Tang MD, Zhong Liu MD
Format: Article
Language:English
Published: SAGE Publishing 2025-04-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338251336275
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849325103192473600
author Yang Yang MD
Xinqiao Tang MD
Zhong Liu MD
author_facet Yang Yang MD
Xinqiao Tang MD
Zhong Liu MD
author_sort Yang Yang MD
collection DOAJ
description Introduction Osteosarcoma (OS) is a highly aggressive primary bone malignancy with poor prognosis. Histone modifications play crucial roles in tumor progression, but their systematic investigation in OS remains unexplored. Methods This study integrated single-cell RNA sequencing data and large-scale clinical information to systematically analyze the spatial heterogeneity of histone modifications in OS and their clinical significance. We employed Seurat for single-cell data analysis, CellChat for cell-cell communication network analysis, and LASSO Cox regression to construct a prognostic model. Additionally, we conducted functional enrichment analysis, immune characteristics analysis, and drug sensitivity prediction. Results We identified five major cell types in the OS microenvironment and discovered significant differences in histone modification levels among different cell types, with osteosarcoma cells and endothelial cells exhibiting higher modification levels. Cell-cell communication network analysis revealed the importance of signaling pathways such as SPP1, CypA, MIF, IGFBP, and VEGF in OS. Based on nine histone modification-related genes, we constructed an efficient prognostic model (AUC values of 0.713, 0.845, and 0.888 for 1-, 3-, and 5-year predictions, respectively), which was validated in an external cohort (AUC = 0.808). Immune microenvironment analysis showed significantly higher proportions of CD8+ T cells and Treg cells in the low-risk group. Drug sensitivity analysis revealed that the low-risk group was more sensitive to Imatinib, Rapamycin, and Sunitinib, while the high-risk group was more sensitive to MAPK pathway inhibitors. Conclusion This study systematically revealed the spatial heterogeneity of histone modifications in OS and their clinical significance for the first time, proposing an “epigenetic-immune” regulatory network hypothesis and developing a histone modification-based prognostic model. Our proposed “epigenetic-guided personalized medication strategy” provides new insights for precision treatment of OS, potentially significantly improving patient prognosis.
format Article
id doaj-art-3495f1fb72e543bb9aa958a9de654bd2
institution Kabale University
issn 1533-0338
language English
publishDate 2025-04-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj-art-3495f1fb72e543bb9aa958a9de654bd22025-08-20T03:48:31ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382025-04-012410.1177/15330338251336275Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment CharacteristicsYang Yang MD0Xinqiao Tang MD1Zhong Liu MD2 Department of Orthopedic Surgery, , Xiangtan, Hunan, P.R. China Department of Orthopedic Surgery, , Xiangtan, Hunan, P.R. China , Xiangtan, Hunan, P.R. ChinaIntroduction Osteosarcoma (OS) is a highly aggressive primary bone malignancy with poor prognosis. Histone modifications play crucial roles in tumor progression, but their systematic investigation in OS remains unexplored. Methods This study integrated single-cell RNA sequencing data and large-scale clinical information to systematically analyze the spatial heterogeneity of histone modifications in OS and their clinical significance. We employed Seurat for single-cell data analysis, CellChat for cell-cell communication network analysis, and LASSO Cox regression to construct a prognostic model. Additionally, we conducted functional enrichment analysis, immune characteristics analysis, and drug sensitivity prediction. Results We identified five major cell types in the OS microenvironment and discovered significant differences in histone modification levels among different cell types, with osteosarcoma cells and endothelial cells exhibiting higher modification levels. Cell-cell communication network analysis revealed the importance of signaling pathways such as SPP1, CypA, MIF, IGFBP, and VEGF in OS. Based on nine histone modification-related genes, we constructed an efficient prognostic model (AUC values of 0.713, 0.845, and 0.888 for 1-, 3-, and 5-year predictions, respectively), which was validated in an external cohort (AUC = 0.808). Immune microenvironment analysis showed significantly higher proportions of CD8+ T cells and Treg cells in the low-risk group. Drug sensitivity analysis revealed that the low-risk group was more sensitive to Imatinib, Rapamycin, and Sunitinib, while the high-risk group was more sensitive to MAPK pathway inhibitors. Conclusion This study systematically revealed the spatial heterogeneity of histone modifications in OS and their clinical significance for the first time, proposing an “epigenetic-immune” regulatory network hypothesis and developing a histone modification-based prognostic model. Our proposed “epigenetic-guided personalized medication strategy” provides new insights for precision treatment of OS, potentially significantly improving patient prognosis.https://doi.org/10.1177/15330338251336275
spellingShingle Yang Yang MD
Xinqiao Tang MD
Zhong Liu MD
Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics
Technology in Cancer Research & Treatment
title Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics
title_full Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics
title_fullStr Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics
title_full_unstemmed Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics
title_short Multi-omics Analysis of Histone-related Genes in Osteosarcoma: A Multidimensional Integrated Study Revealing Drug Sensitivity and Immune Microenvironment Characteristics
title_sort multi omics analysis of histone related genes in osteosarcoma a multidimensional integrated study revealing drug sensitivity and immune microenvironment characteristics
url https://doi.org/10.1177/15330338251336275
work_keys_str_mv AT yangyangmd multiomicsanalysisofhistonerelatedgenesinosteosarcomaamultidimensionalintegratedstudyrevealingdrugsensitivityandimmunemicroenvironmentcharacteristics
AT xinqiaotangmd multiomicsanalysisofhistonerelatedgenesinosteosarcomaamultidimensionalintegratedstudyrevealingdrugsensitivityandimmunemicroenvironmentcharacteristics
AT zhongliumd multiomicsanalysisofhistonerelatedgenesinosteosarcomaamultidimensionalintegratedstudyrevealingdrugsensitivityandimmunemicroenvironmentcharacteristics